PATENT CLAIM ANALYSIS

Application Number: 16141856
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "291000"]

Abstract:
The disclosure relates to compounds of formula (I) and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.

Claim (Index 13):
A method of treating a disease or disorder in a subject, wherein the target tissue, cell or organ associated with the pathology of the disease or disorder has FKBP12 levels sufficient to inhibit mTORC1, the method comprising administering to the subject in need thereof a therapeutically effective amount of a compound according to any one of  claims 1  to  9  or a pharmaceutically acceptable salt thereof, or the pharmaceutical composition of  claim 10 , or the pharmaceutical combination of  claim 11 .

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.52778
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13882363', '16126210', '12631116', '14254020', '13370682']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7856791233813831
- 35 USC 102 Novelty (BERT): 0.5115353269004816
- Combined Prediction Score: 0.758264743733293
- Mean Citation Score: 284.3703799999999
- Max Citation Score: 286.76697
- Similarity Product: 196.90879007740617

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test